182 related articles for article (PubMed ID: 11751331)
1. A 3D structure model of integrin alpha 4 beta 1 complex: I. Construction of a homology model of beta 1 and ligand binding analysis.
You TJ; Maxwell DS; Kogan TP; Chen Q; Li J; Kassir J; Holland GW; Dixon RA
Biophys J; 2002 Jan; 82(1 Pt 1):447-57. PubMed ID: 11751331
[TBL] [Abstract][Full Text] [Related]
2. Analysis of ligand-induced and ligand-attenuated epitopes on the leukocyte integrin alpha4beta1: VCAM-1, mucosal addressin cell adhesion molecule-1, and fibronectin induce distinct conformational changes.
Newham P; Craig SE; Clark K; Mould AP; Humphries MJ
J Immunol; 1998 May; 160(9):4508-17. PubMed ID: 9574557
[TBL] [Abstract][Full Text] [Related]
3. Potent alpha 4 beta 1 peptide antagonists as potential anti-inflammatory agents.
Jackson DY; Quan C; Artis DR; Rawson T; Blackburn B; Struble M; Fitzgerald G; Chan K; Mullins S; Burnier JP; Fairbrother WJ; Clark K; Berisini M; Chui H; Renz M; Jones S; Fong S
J Med Chem; 1997 Oct; 40(21):3359-68. PubMed ID: 9341911
[TBL] [Abstract][Full Text] [Related]
4. The novel recognition site in the C-terminal heparin-binding domain of fibronectin by integrin alpha 4 beta 1 receptor on HL-60 cells.
Mohri H; Katoh K; Iwamatsu A; Okubo T
Exp Cell Res; 1996 Feb; 222(2):326-32. PubMed ID: 8598221
[TBL] [Abstract][Full Text] [Related]
5. Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4)beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin.
Yakubenko VP; Lobb RR; Plow EF; Ugarova TP
Exp Cell Res; 2000 Oct; 260(1):73-84. PubMed ID: 11010812
[TBL] [Abstract][Full Text] [Related]
6. Mucosal addressin cell adhesion molecule-1: a structural and functional analysis demarcates the integrin binding motif.
Viney JL; Jones S; Chiu HH; Lagrimas B; Renz ME; Presta LG; Jackson D; Hillan KJ; Lew S; Fong S
J Immunol; 1996 Sep; 157(6):2488-97. PubMed ID: 8805649
[TBL] [Abstract][Full Text] [Related]
7. Similar but nonidentical amino acid residues on vascular cell adhesion molecule-1 are involved in the interaction with alpha 4 beta 1 and alpha 4 beta 7 under different activity states.
Chiu HH; Crowe DT; Renz ME; Presta LG; Jones S; Weissman IL; Fong S
J Immunol; 1995 Dec; 155(11):5257-67. PubMed ID: 7594538
[TBL] [Abstract][Full Text] [Related]
8. The leukocyte integrin alpha D beta 2 binds VCAM-1: evidence for a binding interface between I domain and VCAM-1.
Van der Vieren M; Crowe DT; Hoekstra D; Vazeux R; Hoffman PA; Grayson MH; Bochner BS; Gallatin WM; Staunton DE
J Immunol; 1999 Aug; 163(4):1984-90. PubMed ID: 10438935
[TBL] [Abstract][Full Text] [Related]
9. Structure-function analysis of the integrin beta 7 subunit: identification of domains involved in adhesion to MAdCAM-1.
Tidswell M; Pachynski R; Wu SW; Qiu SQ; Dunham E; Cochran N; Briskin MJ; Kilshaw PJ; Lazarovits AI; Andrew DP; Butcher EC; Yednock TA; Erle DJ
J Immunol; 1997 Aug; 159(3):1497-505. PubMed ID: 9233649
[TBL] [Abstract][Full Text] [Related]
10. Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses.
Lin Kc; Ateeq HS; Hsiung SH; Chong LT; Zimmerman CN; Castro A; Lee WC; Hammond CE; Kalkunte S; Chen LL; Pepinsky RB; Leone DR; Sprague AG; Abraham WM; Gill A; Lobb RR; Adams SP
J Med Chem; 1999 Mar; 42(5):920-34. PubMed ID: 10072689
[TBL] [Abstract][Full Text] [Related]
11. A cyclic hexapeptide is a potent antagonist of alpha 4 integrins.
Vanderslice P; Ren K; Revelle JK; Kim DC; Scott D; Bjercke RJ; Yeh ET; Beck PJ; Kogan TP
J Immunol; 1997 Feb; 158(4):1710-8. PubMed ID: 9029107
[TBL] [Abstract][Full Text] [Related]
12. Critical amino acid residues for ligand binding are clustered in a predicted beta-turn of the third N-terminal repeat in the integrin alpha 4 and alpha 5 subunits.
Irie A; Kamata T; Puzon-McLaughlin W; Takada Y
EMBO J; 1995 Nov; 14(22):5550-6. PubMed ID: 8521812
[TBL] [Abstract][Full Text] [Related]
13. Human integrin alphavbeta5: homology modeling and ligand binding.
Marinelli L; Gottschalk KE; Meyer A; Novellino E; Kessler H
J Med Chem; 2004 Aug; 47(17):4166-77. PubMed ID: 15293989
[TBL] [Abstract][Full Text] [Related]
14. Transfer of a protein binding epitope to a minimal designed peptide.
Quan C; Skelton NJ; Clark K; Jackson DY; Renz ME; Chiu HH; Keating SM; Beresini MH; Fong S; Artis DR
Biopolymers; 1998; 47(4):265-75. PubMed ID: 10036968
[TBL] [Abstract][Full Text] [Related]
15. Integrin structure.
Humphries MJ
Biochem Soc Trans; 2000; 28(4):311-39. PubMed ID: 10961914
[TBL] [Abstract][Full Text] [Related]
16. Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling.
Calderwood DA; Fujioka Y; de Pereda JM; García-Alvarez B; Nakamoto T; Margolis B; McGlade CJ; Liddington RC; Ginsberg MH
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2272-7. PubMed ID: 12606711
[TBL] [Abstract][Full Text] [Related]
17. Identification of ligand binding sites on integrin alpha4beta1 through chemical cross-linking.
Chen LL; Lobb RR; Cuervo JH; Lin Kc; Adams SP; Pepinsky RB
Biochemistry; 1998 Jun; 37(24):8743-53. PubMed ID: 9628736
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of VCAM-1 and fibronectin binding to integrin alpha 4 beta 1: implications for integrin function and rational drug design.
Humphries MJ; Sheridan J; Mould AP; Newham P
Ciba Found Symp; 1995; 189():177-91; discussion 191-9. PubMed ID: 7587632
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the alpha4beta1 integrin-osteopontin interaction.
Barry ST; Ludbrook SB; Murrison E; Horgan CM
Exp Cell Res; 2000 Aug; 258(2):342-51. PubMed ID: 10896785
[TBL] [Abstract][Full Text] [Related]
20. The alpha 4 beta 1 fibronectin ligands CS-1, Hep II, and RGD induce different intracellular events in B lymphoid cells. Comparison with the effects of the endothelial ligand VCAM-1.
Domínguez-Jiménez C; Sánchez-Aparicio P; Albar JP; García-Pardo A
Cell Adhes Commun; 1996 Nov; 4(4-5):251-67. PubMed ID: 9117345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
